Embryo preservation often works for cancer patients

By Karla Gale

NEW YORK (Reuters Health) - Freezing embryos before undergoing cancer treatment that may cause infertility is as successful for women with cancer as it is for women without cancer, new study findings indicate.

The investigators, who presented their findings this week at the 64th annual meeting of the American Society of Reproductive Medicine in San Francisco, recommend this means preserving fertility for cancer patients, because the ovaries are severely compromised by chemotherapy and radiation.

“There have been few data looking at the clinical performance outcome of those few young cancer patients who do seek embryo cryopreservation” before they undergo toxic treatment, presenter Dr. Bo Yu told Reuters Health.

The research team at New York-Presbyterian Hospital/Columbia University Medical Center reviewed the records of 12 patients younger than age 40 (9 with breast cancer and 1 each with colon cancer, rectal cancer, and synovial cell sarcoma) and 48 age-matched control subjects.

The numbers of mature eggs obtained were similar in the two groups (10.8 vs. 9.2), the investigators reported, and the fertilization rates were also comparable (64 percent vs. 67 percent).

“In early stage cancer, there is a window of at least 6 weeks after surgery that allows patients to recover from surgery and has been proven to be a safe waiting period before starting chemotherapy or radiation,” Yu noted. “This is the window of opportunity for patients to consider fertility preservation treatments without causing any delay in the start of cancer treatment.”

In a second study, the physicians evaluated the effect of chemotherapy on ovarian function in 26 young women with stage I and II breast cancer. The patients were treated with Adriamycin, cyclophosphamide and paclitaxel for 6 months.

Chemotherapy decreased ovarian reserve “rapidly and dramatically.” Although hormone levels recovered quickly, with 58 percent of women regaining menstrual function by 52 weeks, all ovarian reserves remained below the normal range.

However, despite the concern of reduced fertility after chemotherapy, “we have documented that pregnancy can occur,” the investigators reported.

“One thing we hope to achieve through publishing our research is to increase awareness among physicians and patients of the gonadotoxic effects of chemotherapy,” she said. “Physicians should counsel patients newly diagnosed with cancer to consider fertility preservation treatments before…injury occurs.”


Related Posts:

LONDON (Reuters) - Greek researchers have identified the chemotherapy combinations that appear to help women with advanced breast cancer live longest, they reported Tuesday. Women who took a combination of a taxane-based therapy such as Taxol or paclitaxel, or Sanofi Aventis’s Taxotere, known generically as docetaxel, with other drugs lived a year longer than women who

Full Post: Certain chemotherapy combinations work best

By Amy Norton NEW YORK (Reuters Health) - Obese women may have a higher risk of developing ovarian cancer than their thinner counterparts, a large study of U.S. women suggests. Ovarian cancer is a particularly deadly type of cancer because in the initial stages it typically has vague symptoms or none at all, making it difficult to

Full Post: Obesity may raise risk of ovarian cancer

NEW YORK (Reuters Health) - Painful swelling of the arm or shoulder area following treatment for breast cancer — a condition called lymphedema - is more common in women who are overweight or obese than in women of normal weight, researchers have found. Lymphedema is a common, chronic condition that often develops after breast surgery involving

Full Post: Obesity raises risk of cancer-related lymphedema

NEW YORK (Reuters Health) - For young women with fibroids — benign tumors inside the uterus that can lead to pain, abnormal bleeding and other symptoms — a treatment called uterine artery embolization (UAE) does not harm fertility, according to results of a study conducted in Spain. Hysterectomy, the traditional operation for fibroids, solves the problem

Full Post: Pregnancy possible after fibroid treatment

By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - It may be possible to predict which breast cancer patients will be helped by tamoxifen based on changes in so-called breast density, researchers reported on Saturday. Women with dense breasts — a term meaning they have more non-fatty tissue — are known to have a higher risk

Full Post: Breast changes tell whether treatment works: study

Site Navigation

Most Read



  • kinwrite.com@gmail.com